Cargando…
Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach
Over the past decade, precision cancer medicine has driven major advances in the management of advanced solid tumours with the identification and targeting of putative driver aberrations transforming the clinical outcomes across multiple cancer types. Despite pivotal advances in the characterization...
Autores principales: | Coleman, Niamh, Ameratunga, Malaka, Lopez, Juanita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833160/ https://www.ncbi.nlm.nih.gov/pubmed/29511362 http://dx.doi.org/10.1177/1179554918759079 |
Ejemplares similares
-
CNS cancer immunity cycle and strategies to target this for glioblastoma
por: Ameratunga, Malaka, et al.
Publicado: (2018) -
Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials
por: Lopez, Juanita, et al.
Publicado: (2015) -
Dramatic clinical response in the treatment of small cell glioblastoma multiforme
por: Zaman, Farzana Yasmin, et al.
Publicado: (2022) -
Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma
por: Matsui, Jennifer K., et al.
Publicado: (2022) -
The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma
por: Liu, Xudong, et al.
Publicado: (2023)